JPH0631201B2 - Process for producing optically active γ-lactone derivative - Google Patents
Process for producing optically active γ-lactone derivativeInfo
- Publication number
- JPH0631201B2 JPH0631201B2 JP1140799A JP14079989A JPH0631201B2 JP H0631201 B2 JPH0631201 B2 JP H0631201B2 JP 1140799 A JP1140799 A JP 1140799A JP 14079989 A JP14079989 A JP 14079989A JP H0631201 B2 JPH0631201 B2 JP H0631201B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- optically active
- compound
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、G.Storkらによって開発されたプロスタグラ
ンジン合成法(G.Stork,T.Takahashi,I.Kawamoto,T.
Suzuki:J.Am.Chem.Soc.,100,8272(1978))における
重要な中間体である、下記一般式(P) (上記一般式(P)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又は
アシル基、シリル基、アラルキル基及びアルキルオキシ
アルキル基から選ばれた容易に脱離可能な保護基を表わ
し、*の符号は不斉炭素原子を表わす) で表わされる光学活性γ−ラクトン誘導体の製法に関す
る。DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention relates to a prostaglandin synthesis method (G.Stork, T.Takahashi, I.Kawamoto, T.) developed by G.Stork et al.
Suzuki: J. Am. Chem. Soc., 100 , 8272 (1978)), the following general formula (P) (In the general formula (P), R 1 has 1 to 12 carbon atoms selected from an alkyl group optionally having an alkoxy group, a cycloalkyl group and an aralkyl group having a hetero atom in an aromatic ring or an alkyl group. The group R 2 represents a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group and an alkyloxyalkyl group, and the symbol * represents an asymmetric carbon atom). It relates to a method for producing an optically active γ-lactone derivative.
(従来の技術及び解決すべき課題) プロスタグランジンの製造に関しては、上記G.Storkら
の合成法の他に、コーリーラクトンや4−ヒドロキシシ
クロペンテノンより出発する方法が実用化されている
が、この方法は原料の光学活性体を得るために光学分割
や微生物による不斉水解などの工程を経る必要があり、
さらにこれらを基にしてα,ω側鎖を導入していく段階
での立体制御においても問題点が多い。このような点か
らみると上記G.Storkらにより開発された前記一般式
(P)の光学活性γ−ラクトン誘導体を鍵中間体とする
プロスタグランジン合成法は優れた方法であるといえ
る。しかしながら、この方法における問題点は鍵中間体
となる一般式(P)の化合物をいかに経済的に製造でき
るかにかかっていた。(Prior Art and Problems to be Solved) Regarding the production of prostaglandins, in addition to the synthetic method of G. Stork et al., A method starting from corey lactone or 4-hydroxycyclopentenone has been put into practical use. , This method needs to undergo steps such as optical resolution and asymmetric hydrolysis by microorganisms in order to obtain the optically active substance of the raw material,
Furthermore, there are many problems in stereocontrol at the stage of introducing α and ω side chains based on these. From this point of view, it can be said that the prostaglandin synthesis method developed by G. Stork et al. Using the optically active γ-lactone derivative of the general formula (P) as a key intermediate is an excellent method. However, the problem in this method depends on how economically the compound of the general formula (P), which is a key intermediate, can be produced.
(課題を解決するための手段) 本発明者らは、上記問題点を解決すべく鋭意検討の結
果、鍵中間体である本発明の上記一般式(P)で表わさ
れる化合物を従来より簡便に、且つ効率よく製造する方
法を見出したものである。(Means for Solving the Problems) As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that a compound represented by the above general formula (P) of the present invention, which is a key intermediate, can be more easily prepared than ever before. In addition, the present invention has found a method of efficiently manufacturing the same.
本発明は、下記一般式(B) (上記一般式(B)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又は
アシル基、シリル基、アラルキル基及びアルキルオキシ
アルキル基から選ばれた容易に脱離可能な保護基、R4
は炭素数1〜5の低級アルキル基を表わし、*の符号は
不斉炭素原子を表わす) で表わされる光学活性化合物を酸触媒の存在下で分子内
閉環させることを特徴とする下記一般式(P)で表わさ
れる光学活性γ−ラクトン誘導体の製法である。The present invention includes the following general formula (B) (In the general formula (B), R 1 has 1 to 12 carbon atoms selected from an alkyl group which may have an alkoxy group, a cycloalkyl group and an aralkyl group having a hetero atom in an aromatic ring or an alkyl group. R 2 is a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group and an alkyloxyalkyl group, R 4
Represents a lower alkyl group having 1 to 5 carbon atoms, and the symbol * represents an asymmetric carbon atom), and an optically active compound represented by the formula (I) is subjected to intramolecular ring closure in the presence of an acid catalyst. P) is a method for producing an optically active γ-lactone derivative.
上記一般式(P)において、R1,R2及び*の符号は一
般式(B)のR1,R2及び*の符号と同じ意味を表わ
す。 In formula (P), the same meanings as R 1, R 2 and * symbols R 1, R 2 and * symbols are the general formula (B).
上記一般式(P)におけるR1の具体例としては、メチ
ル,エチル,プロピル,イソプロピル、ブチル,イソブ
チル,ペンチル,イソペンチル,2,2−ジメチルペンチ
ル,ヘキシル,2−ヘキシル,ヘプチル,2−ヘプチ
ル,オクチル,2−オクチル,ノニル,2−ノニル,デ
シル,2−デシル,ウンデシル,2−ウンデシル、ドデ
シル,2−エトキシ−1,1−ジメチルエチル,5−メト
キシ−1−メチルペンチル,シクロペンチル,3−エチ
ルシクロペンチル,シクロヘキシル,2−メチルシクロ
ヘキシル,4−n−プロピルシクロヘキシルなどのアル
コキシ置換基を有していてもよい直鎖状もしくは分岐状
アルキル基又はシクロアルキル基、フェニルオキシメチ
ル,3−トリフルオロメチルフェニルオキシメチル,2
−クロロチオフェン−5−イルオキシメチル,フラン−
2−イル−2−エチルなどの芳香環もしくはアルキル基
にヘテロ原子を有するアラルキル基が挙げられる。Specific examples of R 1 in the general formula (P) include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, 2,2-dimethylpentyl, hexyl, 2-hexyl, heptyl, 2-heptyl, Octyl, 2-octyl, nonyl, 2-nonyl, decyl, 2-decyl, undecyl, 2-undecyl, dodecyl, 2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl, 3- A linear or branched alkyl group or cycloalkyl group which may have an alkoxy substituent such as ethylcyclopentyl, cyclohexyl, 2-methylcyclohexyl, 4-n-propylcyclohexyl, phenyloxymethyl, 3-trifluoromethyl Phenyloxymethyl, 2
-Chlorothiophen-5-yloxymethyl, furan-
Examples thereof include an aralkyl group having a hetero atom in an aromatic ring or an alkyl group such as 2-yl-2-ethyl.
上記一般式(P)における水素原子以外のR2の具体例
としては、ベンゾイル,アセチル,p−フェニルベンゾ
イルなどのアシル基、t−ブチルメチルシリル,トリメ
チルシリル,t−ブチルジフェニルシリルなどのシリル
基、ベンジル,4−ニトロフェニルメチルなどのアラル
キル基、テトラヒドロピラニル,1−エトキシエチルな
どのアルキルオキシアルキル基等の容易に脱離可能な基
が挙げられる。Specific examples of R 2 other than a hydrogen atom in the general formula (P) include acyl groups such as benzoyl, acetyl and p-phenylbenzoyl, silyl groups such as t-butylmethylsilyl, trimethylsilyl and t-butyldiphenylsilyl, Examples thereof include aralkyl groups such as benzyl and 4-nitrophenylmethyl, and easily removable groups such as alkyloxyalkyl groups such as tetrahydropyranyl and 1-ethoxyethyl.
プロスタグランジンは生体内でプロスタグランジン合成
酵素によりアラキドン酸などの高級不飽和脂肪酸が化学
変換されて生じる極めて強い生理活性をもつ化合物で下
記のような構造を有している。Prostaglandins are compounds having extremely strong physiological activity, which are produced by the chemical conversion of higher unsaturated fatty acids such as arachidonic acid by prostaglandin synthase in vivo and have the following structures.
天然のプロスタグランジンでは、R1はn−C5H11−、
Rは(CH2)6COOH又はCH2CH=CH(CH2)
3COOHであり、R1の置換基は脂溶性を有することが
生理活性の発現上重要であることが知られている。医薬
品としての開発研究が進められる中でさらにR1として
アルキル基、シクロアルキル基又はアラルキル基であっ
て炭素数4〜10のものが有効であり、例えばペンチル,
イソペンチル,2,2−ジメチルペンチル,ヘキシル,2
−ヘキシル,ヘプチル、2−エトキシ−1,1−ジメチル
エチル,5−メトキシ−1−メチルペンチルなどのアル
キル基、シクロペンチル,3−エチルシクロペンチル,
4−プロピルシクロヘキシルなどのシクロアルキル基、
フェニルオキシメチル,3−トリフルオロメチルフェニ
ルオキシメチル,2−クロロチオフェン−5−イルオキ
シメチル,フラン−2−イル−2−エチルなどのアラル
キル基などが特に強い生理活性を示すことが明らかにさ
れてきた。本発明の化合物はこれら有機基を含めた置換
基を導入することのできる原料として有用なものであ
る。 In natural prostaglandins, R 1 is n-C 5 H 11- ,
R is (CH 2 ) 6 COOH or CH 2 CH = CH (CH 2 )
It is known that it is 3 COOH and that the substituent of R 1 has lipophilicity in order to exert physiological activity. In the course of development and research as pharmaceuticals, R 1 is more preferably an alkyl group, a cycloalkyl group or an aralkyl group having 4 to 10 carbon atoms, such as pentyl,
Isopentyl, 2,2-dimethylpentyl, hexyl, 2
-Alkyl groups such as hexyl, heptyl, 2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl, 3-ethylcyclopentyl,
A cycloalkyl group such as 4-propylcyclohexyl,
It has been clarified that aralkyl groups such as phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2-chlorothiophen-5-yloxymethyl and furan-2-yl-2-ethyl have particularly strong physiological activity. Came. The compound of the present invention is useful as a raw material into which a substituent including these organic groups can be introduced.
本発明の上記一般式(P)で表わされるγ−ラクトン誘
導体の合成法を以下合成経路Iに従って説明する。下記
において、Xはハロゲン原子、Mはアルカリ金属を表わ
す。The synthetic method of the γ-lactone derivative represented by the above general formula (P) of the present invention will be described below according to the synthetic route I. In the following, X represents a halogen atom and M represents an alkali metal.
上記反応において、ハロゲン化合物(1)にn−ブチル
リチウム,t−ブチルリチウム,メチルリチウム,リチ
ウムジイソプロピルアミドなどの強塩基を作用させてア
セチレン化合物(2)とし、さらにこれらの強塩基によ
りアルカリ金属アセチリド(2′)とする。これに光学
活性アルデヒド(3)を作用させると化合物(4)が得
られる。 In the above reaction, the halogen compound (1) is reacted with a strong base such as n-butyllithium, t-butyllithium, methyllithium, lithium diisopropylamide to give an acetylene compound (2), and the alkali metal acetylide is further added with these strong bases. (2 '). The compound (4) is obtained by reacting this with an optically active aldehyde (3).
上記アルカリ金属アセチリド(2′)は、上記のように
アセチレン化合物(2)を一度単離して再度強塩基と反
応させて調製してもよいが、より簡便にはハロゲン化合
物(1)を2倍量以上の強塩基と反応させて得られるア
ルカリ金属アセチリドをそのまま用いることができる。
このアルカリ金属アセチリドと光学活性アルデヒド
(3)との反応は−78〜0℃の低温で行うことが望まし
い。化合物(4)を得る反応はテトラヒドロフラン,ジ
イソプロピルエーテル,トルエンなどの不活性溶媒中−
78℃〜室温の温度範囲で行うことができる。この反応に
よって得られる化合物(4)は下記化学式で示されるよ
うにエリトロ体(6−1)とトレオ体(6−2)の混合
物である。The above-mentioned alkali metal acetylide (2 ′) may be prepared by isolating the acetylene compound (2) once and reacting it with a strong base again as described above. The alkali metal acetylide obtained by reacting with an amount of a strong base or more can be used as it is.
The reaction between the alkali metal acetylide and the optically active aldehyde (3) is preferably carried out at a low temperature of -78 to 0 ° C. The reaction for obtaining the compound (4) is carried out in an inert solvent such as tetrahydrofuran, diisopropyl ether or toluene.
It can be performed in the temperature range of 78 ° C to room temperature. The compound (4) obtained by this reaction is a mixture of the erythro body (6-1) and the threo body (6-2) as shown by the following chemical formula.
この混合物からエリトロ体(6−1)又はトレオ体(6
−2)を選択的に得るにはカラム分離などによって分割
することができるが、後述するような化学的方法によっ
て簡便に、しかもより選択的にそれぞれの光学異性体を
製造することができる。この化合物(4)に酸化剤、例
えばCrO3−ピリジン,ジメチルスルホキシド(DM
SO)−酸ハライドなどを用いて酸化することにより化
合物(5)のエチニルケトン誘導体を得ることができ
る。 From this mixture, the erythro body (6-1) or the threo body (6)
In order to selectively obtain -2), it can be separated by column separation or the like, but each optical isomer can be produced easily and more selectively by a chemical method as described later. An oxidant such as CrO 3 -pyridine or dimethyl sulfoxide (DM) is added to the compound (4).
The ethynyl ketone derivative of the compound (5) can be obtained by oxidation with (SO) -acid halide or the like.
この化合物(5)より光学活性エチニルアルコール誘導
体(6)を合成する反応は、得ようとするエチニルアル
コール誘導体(6)が前記化学式で示したエリトロ体
(6−1)であるか、またはトレオ体(6−2)である
かによって反応条件が異なる。即ち、エリトロ体(6−
1)を目的とする場合は化合物(5)を水素化ホウ素亜
鉛錯体(Zn(BH4)2)で、またトレオ体(6−2)
を目的とする場合はアルカリ金属セレクトリド、例えば
カリウムセレクトリドで還元することにより良好な選択
性をもって目的とする立体配置のエチニルアルコール誘
導体(6)を得ることができる。In the reaction for synthesizing the optically active ethynyl alcohol derivative (6) from the compound (5), the ethynyl alcohol derivative (6) to be obtained is the erythro body (6-1) represented by the above chemical formula, or a threo body. The reaction conditions differ depending on whether it is (6-2). That is, the erythro body (6-
For the purpose of 1), the compound (5) is a zinc borohydride complex (Zn (BH 4 ) 2 ) and the threo compound (6-2).
In the case of aiming at, the ethynyl alcohol derivative (6) having the desired configuration can be obtained with good selectivity by reducing with an alkali metal selectlide, for example, potassium selectride.
上記エチニルアルコール誘導体(6)よりアリルアルコ
ール誘導体(7)を合成するには、エチニルアルコール
誘導体(6)に水素化リチウムアルミニウム等で三重結
合をトランス二重結合へ還元することによって得ること
ができる。この反応はテトラヒドロフラン,ジオキサン
等の不活性溶媒中40〜80℃の温度で行うことができる。To synthesize the allyl alcohol derivative (7) from the ethynyl alcohol derivative (6), the ethynyl alcohol derivative (6) can be obtained by reducing the triple bond to a trans double bond with lithium aluminum hydride or the like. This reaction can be carried out in an inert solvent such as tetrahydrofuran or dioxane at a temperature of 40 to 80 ° C.
アリルアルコール誘導体(7)は、下記一般式(D) CH3C(OR4)3 (D) (上記一般式(D)において、R4は炭素数1〜5の低
級アルキル基を表わす) で表わされるオルト酢酸トリアルキルと共に酸触媒の存
在下で加熱反応させ、ジョンソン−クライゼン転位反応
を行ってγ−不飽和カルボン酸誘導体(B)に変換され
る。用いる一般式(D)で表わされるオルト酢酸トリア
ルキルとしてはオルト酢酸トリメチル,オルト酢酸トリ
エチル,オルト酢酸トリプロピル,オルト酢酸トリブチ
ル,オルト酢酸トリヘプチル等が挙げられ、これをアリ
ルアルコール誘導体(7)に対して2〜10倍当量用い、
トルエン,キシレン,メシチレン等の溶媒中130〜180℃
の温度で反応が行われる。酸触媒としてはルイス酸、ル
イス酸錯体(例えばBF3・(C2H5)2O)やヘプタン
酸などの有機酸が用いられる。このようにして得られた
γ−不飽和カルボン酸誘導体(B)のアセトニドを酸触
媒で開環させ、分子内ラクトン化させるとプロスタグラ
ンジン合成における鍵中間体である本発明の一般式
(P)で表わされる光学活性γ−ラクトン誘導体が得ら
れる。この反応におけるアセトニドの加水分解は含水有
機酸、メタノール,エタノール等のアルコール、アセト
ン又はジオキサンなどの溶媒中鉱酸やBF3・エーテル
錯体,CuSO4,ZnSO4等のルイス酸又はルイス酸
錯体を用いて室温〜80℃の温度で行うことができる。The allyl alcohol derivative (7) is represented by the following general formula (D) CH 3 C (OR 4 ) 3 (D) (in the general formula (D), R 4 represents a lower alkyl group having 1 to 5 carbon atoms). It is converted into a γ-unsaturated carboxylic acid derivative (B) by heating and reacting with the represented trialkyl orthoacetate in the presence of an acid catalyst to carry out a Johnson-Claisen rearrangement reaction. Examples of the trialkyl orthoacetate represented by the general formula (D) to be used include trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, tributyl orthoacetate, triheptyl orthoacetate, etc. 2-10 times equivalent,
130-180 ℃ in solvents such as toluene, xylene, mesitylene
The reaction is carried out at the temperature of. As the acid catalyst, a Lewis acid, a Lewis acid complex (for example, BF 3. (C 2 H 5 ) 2 O), or an organic acid such as heptanoic acid is used. When the acetonide of the thus obtained γ-unsaturated carboxylic acid derivative (B) is ring-opened with an acid catalyst and subjected to intramolecular lactonization, the general formula (P of the present invention, which is a key intermediate in prostaglandin synthesis, is used. An optically active γ-lactone derivative represented by Hydrolysis containing organic acid acetonide in this reaction, using methanol, ethanol and the like alcohol, solvent mineral acid and BF 3 · ether complex, such as acetone or dioxane, CuSO 4, ZnSO 4 Lewis acid or a Lewis acid complex such as Can be performed at room temperature to 80 ° C.
このようにして得られた一般式(P)の化合物は、前記
G.Storkらのプロスタグランジン合成法に従ってプロス
タグランジン(前記PGE、PGF)に導くことができ
る。従って本発明における一般式(P)の光学活性化合
物は、上記原料としては一般式(P)中の3位,3′位
及び4位の立体配置は共にSであることが必要とされ
る。The compound of the general formula (P) thus obtained is
Prostaglandins (PGE, PGF) can be derived according to the prostaglandin synthesis method of G. Stork et al. Therefore, the optically active compound of the general formula (P) in the present invention is required to have S as the three-dimensional configuration of the 3-position, 3′-position and 4-position in the general formula (P) as the above-mentioned raw material.
上記反応における出発物質であるハロゲン化合物(1)
は、D−マンニトールや光学活性グリシドールから公知
の方法で得られる光学活性2,3−0−イソプロピリデン
グリセルアルデヒドをトリフェニルホスフィン及びテト
ラハロメタンと反応させることにより容易に合成でき
る。Halogen compound (1) as a starting material in the above reaction
Can be easily synthesized by reacting optically active 2,3-0-isopropylideneglyceraldehyde obtained from D-mannitol or optically active glycidol by a known method with triphenylphosphine and tetrahalomethane.
また、上記光学活性アルデヒド(3)は、下記合成経路
IIに従って合成することができる。下記において、
R1,R2及び*の符号は一般式(A)のR1,R2及び*
の符号と同様の意味を表わし、X,Yは、それぞれ独立
して水酸基,アシル基,スルホキシ基及びハロゲン原子
から選ばれた基又は原子を表わす。In addition, the above-mentioned optically active aldehyde (3) is obtained by the following synthetic route.
It can be synthesized according to II. In the following,
R 1 of R 1, R 2 and * symbols are the general formula (A), R 2 and *
And X and Y each independently represent a group or atom selected from a hydroxyl group, an acyl group, a sulfoxy group and a halogen atom.
上記光学活性マンニトールをアセトンと酸触媒の存在下
で反応させてトリアセトニド(a)とし、これを含水酢
酸で部分加水分解してテトラオール(b)とし、これの
一級水酸基及び二級水酸基を各々別個にトリフェニルホ
スフィン−CCl4,酸ハライド−ピリジン,ピリジン−
メタンスルホニルクロリドなどで選択的にアシル基,ス
ルホキシ基又はハロゲン原子で一部又は全部を変換して
アセトニド(c)とする。次いでこのアセトニド(c)
を塩基でジエポキシド(d)とした後、R3MgBr,
R3MgBr−Cu2(CN)2,R3Li(但し、R3は
R1より炭素数が1個少ない基を表わす)や水素化リチ
ウムアルミニウムなどでR1基を導入し、さらに水酸基
をR2X′(X′はハロゲン原子又はスルホキシ基)と
反応させてアセトニド(e)とし、これを加水分解して
ジオール(f)とした後、Pb(OAc)4やNaIO4
などで酸化して目的の光学活性アルデヒド(3)を得る
ことができる。 The optically active mannitol is reacted with acetone in the presence of an acid catalyst to give triacetonide (a), which is partially hydrolyzed with hydrous acetic acid to give tetraol (b), which has primary and secondary hydroxyl groups separately. Triphenylphosphine-CCl 4 , acid halide-pyridine, pyridine-
Acetonide (c) is obtained by partially or completely converting with an acyl group, a sulfoxy group or a halogen atom with methanesulfonyl chloride or the like. Then this acetonide (c)
To a diepoxide (d) with a base, then R 3 MgBr,
R 3 MgBr-Cu 2 (CN ) 2, R 3 Li ( where, R 3 represents one less group with a carbon number of from R 1) introducing a group R 1 and the like or lithium aluminum hydride, a further hydroxyl group After reacting with R 2 X '(X' is a halogen atom or a sulfoxy group) to give an acetonide (e), which is hydrolyzed to give a diol (f), Pb (OAc) 4 or NaIO 4
For example, the desired optically active aldehyde (3) can be obtained by oxidization.
以下実施例によって本発明を説明する。The present invention will be described below with reference to examples.
(実施例) 実施例 〈化合物(a)の合成〉 45gのD−マンニトールをアセトン1及び濃塩酸1m
中で室温下3日間激しく攪拌した後、炭酸カリウム50
gを加え、さらに1日攪拌した。固形物を吸引濾過して
除き、濾液中の溶媒を減圧下に留去し、得られた残渣に
水を加え、析出した結晶を吸引濾取して粗生成物45gを
得た。これをエタノール20mに加熱溶解した後濾過
し、濾液を室温に冷却して析出した結晶を濾取し、下記
化学式で示される光学活性(2R,3R,4R,5R)体のトリア
セトニド(a)37.3g(収率50%)を得た。(Example) Example <Synthesis of Compound (a)> 45 g of D-mannitol was added to acetone 1 and concentrated hydrochloric acid 1 m.
After stirring vigorously at room temperature for 3 days, potassium carbonate 50
g was added, and the mixture was further stirred for 1 day. The solid matter was removed by suction filtration, the solvent in the filtrate was distilled off under reduced pressure, water was added to the obtained residue, and the precipitated crystals were collected by suction filtration to obtain 45 g of a crude product. This was dissolved in 20 m of ethanol by heating and then filtered, the filtrate was cooled to room temperature, and the precipitated crystals were collected by filtration, and the optically active (2R, 3R, 4R, 5R) triacetonide (a) 37.3 represented by the following chemical formula was obtained. g (yield 50%) was obtained.
1HNMR(CCl4) δ:1.40 (6H,s,CH3×2) 1.43 (12H,s,CH3×4) 3.7〜4.4(8H,m,CH2,CH) 〈化合物(b)の合成〉 上記得られたトリアセトニド(a)15g(0.05mol)を70%
酢酸50m中40℃で3.5時間攪拌した後、40℃で出来丈
速やかに減圧濃縮し、残渣にアセトンを加え結晶化した
D−マンニトール(0.72g)を濾別し、濾液よりアセト
ンを減圧留去してシロップ状の生成物を得た。これをベ
ンゼン50mで再結晶して下記化学式で示される光学活
性(2R,3R,4R,5R)体のテトラオール(b)8.8g(収率80
%)を得た。 1 HNMR (CCl 4 ) δ: 1.40 (6H, s, CH 3 × 2) 1.43 (12H, s, CH 3 × 4) 3.7 to 4.4 (8H, m, CH 2 , CH) <Compound ( Synthesis of b)> Triacetonide (a) 15 g (0.05 mol) obtained above 70%
After stirring at 40 ° C for 3.5 hours in 50m of acetic acid, the mixture was quickly concentrated at 40 ° C under reduced pressure, and acetone was added to the residue to crystallize D-mannitol (0.72g), and acetone was distilled off under reduced pressure from the filtrate. A syrupy product was obtained. This was recrystallized with 50 m of benzene and 8.8 g (yield 80%) of an optically active (2R, 3R, 4R, 5R) tetraol (b) represented by the following chemical formula.
%) Was obtained.
1HNMR(D2O) δ:1.38 (6H,s,CH3×2) 3.3〜4.2(8H,m,CH2,CH) 〈化合物(c)及び(d)の合成〉 上記得られたテトラオール(b)15.3g (0.069mol)、無水ピリジン55m(0.68mol)、CH2C
l250mの溶液中に、−70℃で塩化ベンゾイル16m
(0.138mol)、無水CH2Cl25mの混合液を15分間か
けて滴下し、滴下後更に−30℃で1時間、室温で10時間
攪拌し、反応の完結を薄層クロマトグラフで確認した後
溶媒を減圧留去した。この残渣にメタンスルホニルクロ
リド11.2m(0.144mol)を0℃で20分間かけて加え、更
にこの懸濁液を室温で3日間攪拌した。反応の完結を薄
層クロマトグラフで確認した後、反応混合物にエチルエ
ーテル:ヘキサン=7:3(容量)の混合溶媒100m
を加え、この黄色の懸濁液をセライト−545で濾過し、
溶媒を減圧留去した。得られた褐色の残渣をCH2Cl2で
希釈し、濃塩酸を加えて酸性にした後CH2Cl2で3回抽
出した。抽出物を飽和重曹水、飽和食塩水で順次洗浄し
た後無水硫酸マグネシウムで乾燥し、溶媒を減圧留去し
て下記化学式で示される光学活性(2R,3R,4R,5R)体の褐
色半固体物アセトニド(c)42gを得た。 1 HNMR (D 2 O) δ: 1.38 (6H, s, CH 3 × 2) 3.3 to 4.2 (8H, m, CH 2 , CH) <Synthesis of Compounds (c) and (d)> The tetra obtained above. All (b) 15.3 g (0.069 mol), anhydrous pyridine 55 m (0.68 mol), CH 2 C
l 2 50m solution in benzoyl chloride 16m at -70 ° C
A mixture of (0.138 mol) and anhydrous CH 2 Cl 2 5m was added dropwise over 15 minutes, and after the addition, the mixture was stirred at −30 ° C. for 1 hour and at room temperature for 10 hours, and the completion of the reaction was confirmed by thin layer chromatography. The post-solvent was distilled off under reduced pressure. To this residue was added methanesulfonyl chloride 11.2m (0.144mol) at 0 ° C over 20 minutes, and the suspension was further stirred at room temperature for 3 days. After confirming the completion of the reaction by thin layer chromatography, the reaction mixture was mixed with 100 m of a mixed solvent of ethyl ether: hexane = 7: 3 (volume).
Was added and the yellow suspension was filtered through Celite-545,
The solvent was distilled off under reduced pressure. The obtained brown residue was diluted with CH 2 Cl 2 , acidified by adding concentrated hydrochloric acid, and then extracted with CH 2 Cl 2 three times. The extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to give an optically active (2R, 3R, 4R, 5R) body of a brown semisolid. 42 g of the product acetonide (c) was obtained.
(但し、Msはメチルスルホキシ基、phはフェニル基
を表わす) 上記アセトニド(c)42g、K2CO320gをメタノール13
0m中で15時間攪拌した後、反応液をセライト−545を
通して濾過し、濾液を40℃で減圧濃縮し、エチルエーテ
ル:ヘキサン=7:3(容量)の混合溶媒30mを加え
て再度セライト−545で濾過し、溶媒を40℃で減圧留去
し、さらに減圧蒸留により粗生成物を得た。これをさら
にベンゼンで再結晶して純粋な下記化学式で示される光
学活性(2S,3R,4R,5S)体のジエポキシド(d)2.7g(収
率21%)を得た。 (However, Ms represents a methylsulfoxy group and ph represents a phenyl group.) 42 g of the above acetonide (c) and 20 g of K 2 CO 3 were added to 13 parts of methanol.
After stirring for 15 hours in 0 m, the reaction solution was filtered through Celite-545, the filtrate was concentrated under reduced pressure at 40 ° C., 30 m of a mixed solvent of ethyl ether: hexane = 7: 3 (volume) was added, and Celite-545 was added again. After filtration, the solvent was distilled off under reduced pressure at 40 ° C., and the crude product was obtained by distillation under reduced pressure. This was recrystallized from benzene to obtain 2.7 g (21% yield) of pure optically active (2S, 3R, 4R, 5S) -form diepoxide (d) represented by the following chemical formula.
1HNMR(CDCl3) δ:1.39 (6H,s,CH3×2) 2.6〜2.9(4H,m,CH2×2) 2.95〜3.12(2H,m,CH) 3.7〜3.95(2H,m,CH) 〈化合物(e)及び(f)の合成〉 Cu2(CN)2320mg、無水テトラヒドロフラン100m
の混合物に、別途調製した濃度1.47molのn−ブチルマ
グネシウムブロミドのエーテル溶液64m(94mmol)を
0℃で5分間かけて加えた。さらに5分間攪拌した後、
上記得られたジエポキシド(d)6.48gの無水テトラヒ
ドロフラン50m溶液を0℃で攪拌下10分間かけて滴下
し、さらに1時間攪拌した。反応の完結を薄層クロマト
グラフで確認した後、NH4Clと飽和食塩水で分解し、
30分間攪拌後、エチルエーテルで3回抽出し、エーテ
ル層を1規定塩酸、飽和重曹水、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥して濾過し、濾液の溶
媒を留去して下記化学式で示される光学活性(6S,7R,8R,
9S)体の粗ジオール(e−1)を得た。 1 HNMR (CDCl 3 ) δ: 1.39 (6H, s, CH 3 × 2) 2.6 to 2.9 (4H, m, CH 2 × 2) 2.95 to 3.12 (2H, m, CH) 3.7 to 3.95 (2H, m, CH) <Synthesis of compounds (e) and (f)> Cu 2 (CN) 2 320 mg, anhydrous tetrahydrofuran 100 m
64 m (94 mmol) of a separately prepared ether solution of n-butylmagnesium bromide having a concentration of 1.47 mol was added to the above mixture at 0 ° C. over 5 minutes. After stirring for another 5 minutes,
A solution of 6.48 g of the diepoxide (d) obtained above in 50 m of anhydrous tetrahydrofuran was added dropwise at 0 ° C. over 10 minutes with stirring, and the mixture was further stirred for 1 hour. After confirming the completion of the reaction by thin layer chromatography, it was decomposed with NH 4 Cl and saturated saline,
After stirring for 30 minutes, the mixture was extracted 3 times with ethyl ether, the ether layer was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and filtered, and the solvent of the filtrate was evaporated. Optical activity represented by the following chemical formula (6S, 7R, 8R,
9S) form crude diol (e-1) was obtained.
上記得られた粗ジオール(e−1)を無水テトラヒドロ
フラン30mに溶かし、これに水素化ナトリウム0.48g
(1.07mmol)の無水テトラヒドロフラン100mを還流
下15分間かけて滴下し、さらに1時間攪拌還流した後0
℃に冷却した。この懸濁液にDC−18−クラウンエーテ
ル−6 132mgと臭化ベンジル9.3m(78mmol)を0℃
で加えて4時間攪拌還流した。反応液を減圧濃縮し、1
規定塩酸で分解した後ヘキサンで3回抽出し、抽出液を
飽和重曹水、飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥した後溶媒を減圧留去して下記化学式で示され
る光学活性(6S,7R,8R,9S)体のアセトニド(e−2)を
得た。 The crude diol (e-1) obtained above was dissolved in 30 m of anhydrous tetrahydrofuran, and 0.48 g of sodium hydride was added.
(1.07 mmol) of anhydrous tetrahydrofuran 100 m was added dropwise under reflux for 15 minutes, and the mixture was further stirred and refluxed for 1 hour, and then 0
Cooled to ° C. To this suspension, 132 mg of DC-18-crown ether-6 and 9.3 m (78 mmol) of benzyl bromide were added at 0 ° C.
Was added and the mixture was stirred and refluxed for 4 hours. Concentrate the reaction mixture under reduced pressure to 1
After decomposing it with normal hydrochloric acid and extracting 3 times with hexane, the extract was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the optical activity (6S , 7R, 8R, 9S) acetonide (e-2) was obtained.
(但し、Bnはベンジル基を表わす) 上記アセトニド(e−2)を80%酢酸100m中100℃で
10時間加熱攪拌した後、溶媒を減圧留去し、次いでエチ
ルエーテルで抽出し、抽出液を苛性ソーダ水溶液で洗浄
し、水層はさらにエチルエーテルで抽出し、これらエー
テル層を併せて1規定塩酸、飽和重曹水、食塩水で順次
洗浄して無水硫酸マグネシウムで乾燥した。溶媒を留去
後シリカゲルカラムクロマトグラフィーで精製し(エチ
ルエーテル:ヘキサン=1:4(容量)で溶出)、下記
化学式で示される光学活性(6S,7R,8R,9S)体のジオール
(f)8.66g(化合物(d)よりの収率55%)を得た。 (However, Bn represents a benzyl group.) The above-mentioned acetonide (e-2) was added to 100 m of 80% acetic acid at 100 ° C.
After heating and stirring for 10 hours, the solvent was evaporated under reduced pressure, followed by extraction with ethyl ether, the extract was washed with a caustic soda aqueous solution, and the aqueous layer was further extracted with ethyl ether. The extract was washed successively with saturated aqueous sodium hydrogen carbonate and brine and dried over anhydrous magnesium sulfate. After the solvent was distilled off, the residue was purified by silica gel column chromatography (eluted with ethyl ether: hexane = 1: 4 (volume)), and the optically active (6S, 7R, 8R, 9S) diol (f) represented by the following chemical formula was obtained. 8.66 g (55% yield from compound (d)) was obtained.
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.88 (6H,br,CH3×2) 1.0〜1.8(16H,m,CH2×8) 3.4〜3.7(4H,m,CH) 4.46 (2H,d,J=10.8Hz,CH) 4.62 (2H,d,J=10.8Hz,CH) 7.30 (10H,s,C6H5) 〈化合物(3)の合成〉 上記得られたジオール(f)200mg、 K2CO360mg及び無水ベンゼン4.5m中に四酢酸鉛260
mgを4℃で加えて3分間攪拌した。反応終了後ヘキサン
100mを加え、セライト−545を用いて濾過し、濾液を
飽和重曹水で洗浄し、水層をヘキサンで2回抽出し、ヘ
キサン層を併せて飽和食塩水で洗浄した後無水硫酸マグ
ネシウムで乾燥した。溶媒を留去後、シリカゲルカラム
クロマトグラフィー(エチルエーテル:ヘキサン=1:
2(容量))で精製して(S)−2−ベンジルオキシヘ
プタナール(3)160mg(収率80%)を得た。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.88 (6H, br, CH 3 × 2) 1.0 to 1.8 (16H, m, CH 2 × 8) 3.4 to 3.7 (4H, m, CH) 4.46 (2H, d, J = 10.8Hz, CH) 4.62 (2H, d, J = 10.8Hz, CH) 7.30 (10H, s, C 6 H 5) < synthesis of compound (3)> obtained above Diol (f) 200mg, K 2 CO 3 60mg and lead tetraacetate 260m in anhydrous benzene 4.5m.
mg was added at 4 ° C. and stirred for 3 minutes. Hexane after reaction
100 m was added, and the mixture was filtered through Celite-545, the filtrate was washed with saturated aqueous sodium hydrogen carbonate, the aqueous layer was extracted twice with hexane, the hexane layers were combined, washed with saturated brine, and then dried over anhydrous magnesium sulfate. . After distilling off the solvent, silica gel column chromatography (ethyl ether: hexane = 1: 1)
(S) -2-benzyloxyheptanal (3) (160 mg, yield 80%).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.87 (3H,t,J=5.8Hz,CH3) 1.0〜1.8(8H,m,CH2) 3.73 (1H,dt,J=2.2Hz,6.2Hz,CH) 4.51 (1H,d,J=11.6Hz,CH) 4.65 (1H,d,J=11.6HZ,CH) 7.34 (5H,s,C6H5) 9.64 (1H,d,J=2.2Hz) 〈化合物(4)の合成〉 下記化学式(1) で表わされる(S)−ジブロマイド4.8g(16.8mmol)の
無水テトラヒドロフラン100mを−78℃に冷却し、窒
素雰囲気下で濃度1.62molのブチルリチウム−ヘキサン
溶液16.4m(26.6mmol)を10分間かけて滴下し、−78
℃でさらに1時間、室温で1時間攪拌して光学活性リチ
ウムアセチリド(2′)に変換し、これを−78℃に冷却
して上記得られた(S)−2−ベンジルオキシヘプタナ
ール(3)2.41g(4.4mmol)の無水テトラヒドロフラン20
mを滴下し、30分間更に攪拌した後、塩化アンモニウ
ム水溶液で分解し、エチルエーテルで3回抽出して飽和
食塩水で洗浄した後無水硫酸マグネシウムで乾燥した。
溶媒を減圧留去し、シリカゲルカラムクロマトグラフィ
ー(エチルエーテル:ヘキサン=1:3(容量))で精
製して下記化学式(4)で表わされる(2S,6S)体の化
合物3.81gを得た(収率64%)。このものはエリトロ
体:トレオ体=64:36(重量)の混合物であった。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.87 (3H, t, J = 5.8Hz, CH 3 ) 1.0 to 1.8 (8H, m, CH 2 ) 3.73 (1H, dt, J = 2.2Hz, 6.2Hz, CH) 4.51 (1H, d, J = 11.6Hz, CH) 4.65 (1H, d, J = 11.6HZ, CH) 7.34 (5H, s, C 6 H 5) 9.64 (1H, d, J = 2.2 Hz) <Synthesis of compound (4)> The following chemical formula (1) 100m of anhydrous tetrahydrofuran of 4.8g (16.8mmol) of (S) -dibromide represented by is cooled to -78 ° C, and 16.4m (26.6mmol) of butyllithium-hexane solution having a concentration of 1.62mol is applied for 10 minutes under a nitrogen atmosphere. Drop it, -78
The mixture was further stirred at 1 ° C. for 1 hour and at room temperature for 1 hour to be converted into optically active lithium acetylide (2 ′), which was cooled to −78 ° C. to obtain (S) -2-benzyloxyheptanal (3) obtained above. ) 2.41 g (4.4 mmol) of anhydrous tetrahydrofuran 20
m was added dropwise, the mixture was further stirred for 30 minutes, decomposed with an aqueous solution of ammonium chloride, extracted three times with ethyl ether, washed with saturated saline, and then dried over anhydrous magnesium sulfate.
The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 3 (volume)) to obtain 3.81 g of a (2S, 6S) compound represented by the following chemical formula (4) ( Yield 64%). This was a mixture of erythro body: threo body = 64: 36 (weight).
(但し、Bnはベンジル基を表わす) 〈化合物(5)の合成〉 無水ジメチルスルホキシド680mg(8.7mmol)の無水塩化メ
チレン15m溶液にオキザリルジクロリド0.38m(4.
4mmol)を−70℃で5分間かけて滴下し、さらに10分間
同温度で攪拌した。これに上記得られたエリトロ体:ト
レオ体=64:36の化合物(4)1.00g(2.9mmol)の無水塩
化メチレン4mを滴下し9分間−70℃で攪拌した。こ
れに無水トリエチルアミン2.0m(14mmol)を滴下し
て徐々に室温に戻した後ヘキサンを加え、セライト−54
5を通して濾過し、濾液を1規定塩酸で洗浄した。水層
を塩化メチレンで3回抽出し、抽出物を飽和食塩水で洗
浄し無水硫酸マグネシウムで乾燥した。溶媒を減圧留去
し、シリカゲルカラムクロマトグラフィー(エチルエー
テル:ヘキサン=1:10(容量))で精製し、下記化学
式で示される(2S,6S)体のエチニルケトン誘導体(5)5
50mgを得た(収率55%)。 (However, Bn represents a benzyl group.) <Synthesis of Compound (5)> Oxalyl dichloride 0.38 m (4.4) in anhydrous methylene chloride 15 m solution of anhydrous dimethyl sulfoxide 680 mg (8.7 mmol).
4 mmol) was added dropwise at −70 ° C. over 5 minutes, and the mixture was further stirred for 10 minutes at the same temperature. 4 m of anhydrous methylene chloride of 1.00 g (2.9 mmol) of the compound (4) having the erythro body: threo body = 64: 36 obtained above was added dropwise thereto, and the mixture was stirred for 9 minutes at -70 ° C. Anhydrous triethylamine (2.0 m, 14 mmol) was added dropwise to this, and the temperature was gradually returned to room temperature. Then, hexane was added, and Celite-54
The mixture was filtered through 5, and the filtrate was washed with 1N hydrochloric acid. The aqueous layer was extracted 3 times with methylene chloride, the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 10 (volume)), and the (2S, 6S) ethynyl ketone derivative (5) 5 represented by the following chemical formula was obtained.
50 mg was obtained (yield 55%).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.86 (3H,br,t,J=7.2Hz,CH3) 1.0〜1.9(8H,m,CH2) 1.38 (3H,s,CH3) 1.47 (3H,s,CH3) 4.02 (1H,dd,J=5.6Hz,8.24Hz,CH) 4.18 (1H,dd,J=6.4Hz,8.24Hz,CH) 4.42 (1H,d,J=11.5Hz,CH) 4.70 (1H,d,J=11.5Hz,CH) 4.86 (1H,dd,J=5.6Hz,6.4Hz,CH) 7.31 (5H,s,C6H5) IR νmax(neat) 695,735,835,1060,1220,1320, 1370,1380,1450,1675,2200,2860, 2920,3020cm-1 〈化合物(6)の合成〉 上記得られた(2S,6S)体のエチニルケトン誘導体(5)5
50mg(1.6mmol)の無水エーテル16m中へ−30℃で濃度
0.26molの水素化ホウ素亜鉛−エチルエーテル溶液9.6m
(2.5mmol)を窒素雰囲気下5分間かけて滴下し、さ
らに30分間攪拌した。反応終了後、水及び0.5規定塩酸2
0mを加え、0℃で30分間攪拌した。水層をエチルエ
ーテルで3回抽出し、抽出液を飽和重曹水及び飽和食塩
水で順次洗浄し無水硫酸マグネシウムで乾燥した。溶媒
を減圧留去し、シリカゲルカラムクロマトグラフィー
(エチルエーテル:ヘキサン=1:3(容量))で精製
して下記化学式で示される(2S,5R,6S)体のエチニルアル
コール誘導体(6)(エリトロ体:トレオ体=90:10
(重量))349mgを得た(収率63%)。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.86 (3H, br, t, J = 7.2Hz, CH 3 ) 1.0 to 1.9 (8H, m, CH 2 ) 1.38 (3H, s , CH 3 ) 1.47 (3H, s, CH 3 ) 4.02 (1H, dd, J = 5.6Hz, 8.24Hz, CH) 4.18 (1H, dd, J = 6.4Hz, 8.24Hz, CH) 4.42 (1H, d , J = 11.5Hz, CH) 4.70 (1H, d, J = 11.5Hz, CH) 4.86 (1H, dd, J = 5.6Hz, 6.4Hz, CH) 7.31 (5H, s, C 6 H 5) IR νmax (Neat) 695, 735, 835, 1060, 1220, 1320, 1370, 1380, 1450, 1675, 2200, 2860, 2920, 3020cm -1 <Synthesis of compound (6)> The above obtained (2S, 6S) body Ethynyl ketone derivative of (5) 5
Concentration into 50 mg (1.6 mmol) 16m anhydrous ether at -30 ° C
0.26mol zinc borohydride-ethyl ether solution 9.6m
(2.5 mmol) was added dropwise under a nitrogen atmosphere over 5 minutes, and the mixture was further stirred for 30 minutes. After the reaction, water and 0.5N hydrochloric acid 2
0 m was added, and the mixture was stirred at 0 ° C for 30 minutes. The aqueous layer was extracted 3 times with ethyl ether, and the extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 3 (volume)) and the (2S, 5R, 6S) ethynyl alcohol derivative (6) represented by the following chemical formula (erythro). Body: threo = 90:10
(Weight)) 349 mg was obtained (63% yield).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.87 (3H,br t,J=7.2Hz,CH3) 1.0〜1.8(8H,m,CH2) 1.36 (3H,s,CH3) 1.45 (3H,s,CH3) 3.49 (1H,dt,J=3.8Hz,6.4Hz,CH) 3.88 (1H,dd,J=6.4Hz,7.7Hz,CH) 4.12 (1H,dd,J=6.4Hz,7.7Hz,CH) 4.4〜4.7(1H,m,J=1.5Hz,3.8Hz,CH) 4.59 (2H,s,CH2) 4.69 (1H,ddd,J=1.5Hz,6.4Hz,6.4H
z,CH) 7.30 (5H,s,C6H5)13 CNMR(CDCl3) δ:13.98,22.54,25.27,25.96,26.22, 30.06,31.85,64.16,65.57,69.94, 72.49,81.50,83.70,84.00,100.31, 127.83,128.40,138.21 〈化合物(7)の合成〉 上記得られた(2S,5R,6S)体のエチニルアルコール誘導体
(6)105mg(0.30mmol)の無水テトラヒドロフラン2
m溶液を水素化リチウムアルミニウム24.1mg(0.63mm
ol)の無水テトラヒドロフラン5m中に0℃で加え、
18分間攪拌還流した。反応終了後、酢酸エチル、エタノ
ール、水、0.1規定塩酸を順次加えて分解し、水層をエ
チルエーテルで2回抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後、溶媒を減圧留去
し、シリカゲルカラムクロマトグラフィー(エチルエー
テル:ヘキサン=1:3(容量))で精製して下記化学
式で示される(2S,5R,6S)体のアリルアルコール誘導体
(7)80.1mgを得た(収率76%)。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.87 (3H, br t, J = 7.2 Hz, CH 3 ) 1.0 to 1.8 (8H, m, CH 2 ) 1.36 (3H, s, CH 3) 1.45 (3H, s , CH 3) 3.49 (1H, dt, J = 3.8Hz, 6.4Hz, CH) 3.88 (1H, dd, J = 6.4Hz, 7.7Hz, CH) 4.12 (1H, dd, J = 6.4Hz, 7.7Hz, CH) 4.4~4.7 (1H, m, J = 1.5Hz, 3.8Hz, CH) 4.59 (2H, s, CH 2) 4.69 (1H, ddd, J = 1.5Hz, 6.4Hz 6.4H
z, CH) 7.30 (5H, s, C 6 H 5) 13 CNMR (CDCl 3) δ: 13.98,22.54,25.27,25.96,26.22, 30.06,31.85,64.16,65.57,69.94, 72.49,81.50,83.70,84.00 , 100.31, 127.83, 128.40, 138.21 <Synthesis of Compound (7)> 105 mg (0.30 mmol) of anhydrous tetrahydrofuran 2 of (2S, 5R, 6S) ethynyl alcohol derivative (6) obtained above.
24.1 mg (0.63 mm) of lithium aluminum hydride
ol) in anhydrous tetrahydrofuran 5 m at 0 ° C.,
The mixture was stirred and refluxed for 18 minutes. After completion of the reaction, ethyl acetate, ethanol, water, and 0.1 N hydrochloric acid were sequentially added for decomposition, and the aqueous layer was extracted twice with ethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 3 (volume)) to be represented by the following chemical formula. 80.1 mg of allyl alcohol derivative (7) of (2S, 5R, 6S) form was obtained (yield 76%).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.86 (3H,t,J=5.4Hz,CH3) 1.38 (3H,s,CH3) 1.40 (3H,s,CH3) 1.04〜1.8(8H,m,CH2) 3.2〜3.5(1H,m,CH) 3.52 (1H,dd,J=7.7Hz,7.7Hz,CH) 4.08 (1H,dd,J=6.4Hz,8.0Hz,CH)13 CNMR(CDCl3) δ:14.02,22.61,25.46,25.92,26.72, 29.42,31.93,69.44,72.22,72.56, 82.18,127.72,127.79,128.40,129.89, 132.47,140.60 〈化合物(B)の合成〉 上記得られた(2S,5R,6S)体のアリルアルコール誘導体
(7)80.1mg(0.23mmol)、トリエチルオルトアセテー
ト0.15m(0.82mmol)及び触媒量のヘプタノイックア
シッドをキシレン3m中160℃で20分間加熱反応さ
せ、キシレンと生成したエタノールを減圧留去し、反応
終了後飽和重曹水で分解した。水層をエチルエーテルで
2回抽出し、抽出物を飽和食塩水で洗浄した後無水硫酸
マグネシウムで乾燥した。溶媒を減圧留去後、シリカゲ
ルカラムクロマトグラフィー(エチルエーテル:ヘキサ
ン=1:10(容量))で精製して下記化学式で示される
(1′S,3S,6S)体のγ−不飽和カルボン酸エチ
ル(B)65.6mgを得た(収率68%)。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.86 (3H, t, J = 5.4Hz, CH 3 ) 1.38 (3H, s, CH 3 ) 1.40 (3H, s, CH 3 ) 1.04~1.8 (8H, m, CH 2 ) 3.2~3.5 (1H, m, CH) 3.52 (1H, dd, J = 7.7Hz, 7.7Hz, CH) 4.08 (1H, dd, J = 6.4Hz, 8.0Hz , CH) 13 CNMR (CDCl 3 ) δ: 14.02, 22.61, 25.46, 25.92, 26.72, 29.42, 31.93, 69.44, 72.22, 72.56, 82.18, 127.72, 127.79, 128.40, 129.89, 132.47, 140.60 <of compound (B). Synthesis> The obtained (2S, 5R, 6S) allyl alcohol derivative (7) 80.1 mg (0.23 mmol), triethyl orthoacetate 0.15 m (0.82 mmol) and a catalytic amount of heptanoic acid in xylene 3 m. React with heating at ℃ for 20 minutes, distill off xylene and generated ethanol under reduced pressure, and decompose with saturated aqueous sodium hydrogen carbonate after the reaction. . The aqueous layer was extracted twice with ethyl ether, the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. After the solvent was distilled off under reduced pressure, the residue was purified by silica gel column chromatography (ethyl ether: hexane = 1: 10 (volume)) and the (1 ′S, 3S, 6S) -form γ-unsaturated carboxylic acid represented by the following chemical formula was obtained. 65.6 mg of ethyl (B) was obtained (68% of yield).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.86 (3H,br t,J=7.2Hz,CH3) 1.0〜1.8(8H,m,CH2) 1.33 (3H,s,CH3) 1.41 (3H,s,CH3) 2.40 (1H,dd,J=9.0Hz,14.7Hz,CH) 2.50 (1H,dd,J=5.1Hz,14.7Hz,CH) 2.6〜3.0(1H,m,CH) 3.5〜3.8(2H,m,CH2) 3.9〜4.3(2H,m,CH×2) 4.09 (2H,q,J=7.2Hz,CH2O) 4.31 (1H,d,J=11.7Hz,CH2C6H5) 4.55 (1H,d,J=11.7Hz,CH2C6H5) 5.2〜5.7(2H,m,=CH−) 7.27 (5H,s,C6H5)13 CNMR(CDCl3) δ:14.00,14.25,22.59,25.03,26.30, 31.77,35.72,36.50,41.77,60.32, 66.81,69.79,77.30,79.74,109.08,127.28,127.7
2,128.20,130.84,134.45, 139.00,171.79 〈化合物(P)の合成〉 上記得られた(1′S,3S,6S)体のγ−不飽和カルボン酸エ
チル(B)65mg(0.16mmol)メタノール5m、水1.25
m及びCuSO4・5H2O186mg(0.75mmol)を13時
間攪拌還流した。反応終了後、エチルエーテルを加えて
セライト−545により濾過し、濾液を飽和食塩水で洗浄
した後無水硫酸マグネシウムで乾燥した。溶媒を減圧留
去後、シリカゲルカラムクロマトグラフィー(酢酸エチ
ル:ヘキサン=1:5(容量))で精製して下記化学式
で示される(3S,3′S,4S)体のγ−ラクトン誘導体(P)
35.5mgを得た。(収率69%)。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.86 (3H, br t, J = 7.2Hz, CH 3 ) 1.0 to 1.8 (8H, m, CH 2 ) 1.33 (3H, s, CH 3) 1.41 (3H, s , CH 3) 2.40 (1H, dd, J = 9.0Hz, 14.7Hz, CH) 2.50 (1H, dd, J = 5.1Hz, 14.7Hz, CH) 2.6~3.0 (1H, m, CH) 3.5~3.8 (2H, m, CH 2) 3.9~4.3 (2H, m, CH × 2) 4.09 (2H, q, J = 7.2Hz, CH 2 O) 4.31 (1H, d, J = 11.7Hz, CH 2 C 6 H 5 ) 4.55 (1H, d, J = 11.7Hz, CH 2 C 6 H 5) 5.2~5.7 (2H, m, = CH-) 7.27 (5H, s, C 6 H 5 ) 13 CNMR (CDCl 3 ) δ: 14.00, 14.25, 22.59, 25.03, 26.30, 31.77, 35.72, 36.50, 41.77, 60.32, 66.81, 69.79, 77.30, 79.74, 109.08, 127.28, 127.7.
2,128.20,130.84,134.45,139.00,171.79 <Synthesis of compound (P)> 65 mg (0.16 mmol) methanol of ethyl (B) γ-unsaturated carboxylate of (1 ′S, 3S, 6S) body obtained above 5m, water 1.25
m and CuSO 4 .5H 2 O (186 mg, 0.75 mmol) were stirred and refluxed for 13 hours. After completion of the reaction, ethyl ether was added and the mixture was filtered through Celite-545. The filtrate was washed with saturated saline and dried over anhydrous magnesium sulfate. After the solvent was distilled off under reduced pressure, the residue was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 5 (volume)) and the (3S, 3 ′S, 4S) -form γ-lactone derivative represented by the following chemical formula (P )
35.5 mg was obtained. (Yield 69%).
(但し、Bnはベンジル基を表わす)1 HNMR(CDCl3) δ:0.86 (3H,br t,J=7.2Hz,CH3) 1.0〜1.8(1H,m,CH2) 3.72〜3.9(5H,m,CH2,CH) 4.4〜4.7(1H,m,CH) 4.36 (1H,d,J=11.7Hz,CH2) 4.51 (1H,d,J=11.7Hz,CH2) 5.55 (1H,dd,J=6.7Hz,15.4Hz,=C
H) 5.68 (1H,dd,J=7.7Hz,15.4Hz,=C
H) 7.29 (5H,s,C6H5)13 CNMR(CDCl3) δ:14.00,22.57,24.98,31.69,34.94, 41.02,62.27,70.42,79.50,82.60, 127.52,127.62,128.23,135.62,138.63, 176.48 (発明の効果) 本発明は、プロスタグランジン合成のための鍵中間体と
なる光学活性γ−ラクトン誘導体の製法であり、本法を
用いることにより該誘導体を比較的簡便に、しかも効率
よく製造することができる。 (However, Bn represents a benzyl group) 1 HNMR (CDCl 3 ) δ: 0.86 (3H, br t, J = 7.2Hz, CH 3 ) 1.0 to 1.8 (1H, m, CH 2 ) 3.72 to 3.9 (5H, m, CH 2 , CH) 4.4 to 4.7 (1H, m, CH) 4.36 (1H, d, J = 11.7Hz, CH 2 ) 4.51 (1H, d, J = 11.7Hz, CH 2 ) 5.55 (1H, dd , J = 6.7Hz, 15.4Hz, = C
H) 5.68 (1H, dd, J = 7.7Hz, 15.4Hz, = C
H) 7.29 (5H, s, C 6 H 5) 13 CNMR (CDCl 3) δ: 14.00,22.57,24.98,31.69,34.94, 41.02,62.27,70.42,79.50,82.60, 127.52,127.62,128.23,135.62,138.63 176.48 (Effect of the invention) The present invention is a method for producing an optically active γ-lactone derivative which is a key intermediate for the synthesis of prostaglandins, and by using this method, the derivative can be relatively easily and efficiently produced. Can be manufactured well.
Claims (6)
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又は
アシル基、シリル基、アラルキル基及びアルキルオキシ
アルキル基から選ばれた容易に脱離可能な保護基、R4
は炭素数1〜5の低級アルキル基を表わし、*の符号は
不斉炭素原子を表わす) で表わされる光学活性化合物を酸触媒の存在下で分子内
閉環させることを特徴とする下記一般式(P)で表わさ
れる光学活性γ−ラクトン誘導体の製法。 上記一般式(P)において、R1,R2及び*の符号は一
般式(B)のR1,R2及び*の符号と同じ意味を表わ
す。1. The following general formula (B): (In the general formula (B), R 1 has 1 to 12 carbon atoms selected from an alkyl group which may have an alkoxy group, a cycloalkyl group and an aralkyl group having a hetero atom in an aromatic ring or an alkyl group. R 2 is a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group and an alkyloxyalkyl group, R 4
Represents a lower alkyl group having 1 to 5 carbon atoms, and the symbol * represents an asymmetric carbon atom), and an optically active compound represented by the formula (I) is subjected to intramolecular ring closure in the presence of an acid catalyst. A process for producing an optically active γ-lactone derivative represented by P). In formula (P), the same meanings as R 1, R 2 and * symbols R 1, R 2 and * symbols are the general formula (B).
キル基である請求項1記載の製法。2. The method according to claim 1, wherein R 1 in the general formula (P) is an alkyl group having 4 to 10 carbon atoms.
載の製法。3. The method according to claim 2, wherein the alkyl group is a pentyl group.
請求項1〜3いずれかに記載の製法。4. The method according to claim 1, wherein R 2 in the general formula (P) is an aralkyl group.
記載の製法。5. The aralkyl group is a benzyl group.
The manufacturing method described.
3′S,4S)体である請求項1〜5いずれかに記載の製
法。6. A compound represented by the general formula (P) is optically active (3S,
The method according to any one of claims 1 to 5, which is a 3'S, 4S) body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1140799A JPH0631201B2 (en) | 1989-06-01 | 1989-06-01 | Process for producing optically active γ-lactone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1140799A JPH0631201B2 (en) | 1989-06-01 | 1989-06-01 | Process for producing optically active γ-lactone derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH035470A JPH035470A (en) | 1991-01-11 |
| JPH0631201B2 true JPH0631201B2 (en) | 1994-04-27 |
Family
ID=15277014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1140799A Expired - Lifetime JPH0631201B2 (en) | 1989-06-01 | 1989-06-01 | Process for producing optically active γ-lactone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0631201B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5108943A (en) * | 1991-01-02 | 1992-04-28 | Micron Technology, Inc. | Mushroom double stacked capacitor |
| US5260458A (en) * | 1991-09-26 | 1993-11-09 | Ortho Pharmaceutical Corporation | 2-oxo tetrahydrofuran compounds |
-
1989
- 1989-06-01 JP JP1140799A patent/JPH0631201B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH035470A (en) | 1991-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH05331128A (en) | @(3754/24)r)-@(3754/24)-)-4-cyano-3-hydroxylactic acid t-butyl ester and its production | |
| US4703127A (en) | Process for the preparation of prostanoids | |
| US5292946A (en) | In-situ preparation of diisopinocamphenyl chloroborane | |
| EP0585104B1 (en) | A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor | |
| EP0362816B1 (en) | Cyclopenteneheptanoic acid derivatives and method of preparation thereof | |
| JP2743797B2 (en) | Preparation of optically active compounds | |
| JP2785657B2 (en) | Preparation of optically active compounds | |
| JP2743798B2 (en) | Preparation of optically active compounds | |
| JP2785658B2 (en) | Preparation of optically active compounds | |
| Vasil’ev et al. | Synthesis of (3 S*, 4 R*, 6 E, 10 Z)-3, 4, 7, 11-tetramethyltrideca-6, 10-dienal (faranal) using stereospecific 1, 4-cis-hydrogenation of conjugated double bonds | |
| HU199768B (en) | Process for production of 3,5-dihydroxi-carbonic acid and its derivatives and medical compositions containing them | |
| JPH0651693B2 (en) | Optically active compound | |
| JPS62153259A (en) | (2-chloro-3-oxo-1-alkenyl)-bicyclo[3.3.0]octene derivative and its production method | |
| JPH035470A (en) | Production of optically active gamma-lactone derivative | |
| JPH0651691B2 (en) | Optically active compound | |
| JP2654835B2 (en) | Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production | |
| US5198588A (en) | Optically active isoxazole derivatives and intermediates for preparation thereof | |
| JP2654834B2 (en) | Optically active vinyl compound, intermediate for producing the same, and method for producing them | |
| JP3446225B2 (en) | Cyclopentane derivative and method for producing the same | |
| JP3228486B2 (en) | Hydroxyketone derivative and method for producing the same | |
| JP2893473B2 (en) | Process for producing (+)-equilenin and intermediate | |
| US5266703A (en) | Optically active isoxazole derivatives | |
| US5220074A (en) | Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same | |
| US5210201A (en) | Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same | |
| JPH0651676B2 (en) | (5E) -Prostaglandin E (2) Manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Effective date: 20050418 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070920 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071002 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071129 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20080108 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080115 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20110125 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20110125 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20110125 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |